Phan Ngoc An Huynh

Phan Ngoc An Huynh

Auto-generated profile, based on publicly available information

Phan Ngoc An Huynh

Faculty of Medicine, College of Health Sciences, Nam Can Tho University, Can Tho, Vietnam

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2026 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
TNThanh Luan Nguyen
Thanh Luan Nguyen
HDHoang Ngoc Thao Duong
Hoang Ngoc Thao Duong
TNThi Bao Yen Nguyen
Thi Bao Yen Nguyen
QLQuang Dai Le
Quang Dai Le
PHPhan Ngoc An Huynh
Phan Ngoc An Huynh
PDPhieu Van Duong
Phieu Van Duong
Background: Disturbances in magnesium homeostasis and magnesium supplementation are common in critical illness; however, the association between early intravenous magnesium sulfate administration and clinical outcomes in critically ill patients with pneumonia remains unclear. Methods: This retrospective observational cohort study used data from the Medical Information Mart for Intensive Care IV (version 3.1) database and included critically ill patients admitted to the intensive care unit (ICU) with pneumonia. Patients were classified according to early exposure to intravenous magnesium sulfate, defined as administration from 6 h before to 24 h after ICU admission, or no exposure during this period. The primary outcome was 30-day all-cause mortality, with secondary outcomes including 60-day and 90-day mortality. Associations were evaluated using multivariable Cox proportional hazards models, with prespecified subgroup, interaction, and sensitivity analyses, including propensity score matching. Results: Among 9203 eligible patients, 2975 (32.3%) received early intravenous magnesium sulfate. Magnesium sulfate administration was associated with lower 30-day mortality after multivariable adjustment (adjusted hazard ratio [aHR] 0.84; 95% confidence interval [CI] 0.76-0.94; p = .002). Similar associations were observed for 60-day mortality (aHR 0.86; 95% CI 0.78-0.95; p = .002) and 90-day mortality (aHR 0.87; 95% CI 0.80-0.96; p = .004). Subgroup analysis identified a significant interaction for sepsis status (p for interaction = .007). In a propensity score–matched cohort, magnesium sulfate administration remained associated with lower 30-day mortality (aHR 0.85; 95% CI 0.74-0.96; p = .012). Conclusions: In critically ill patients with pneumonia, early intravenous magnesium sulfate administration was associated with lower mortality. These findings are hypothesis-generating and suggest the need for prospective studies to clarify causality and define optimal dosing and duration of magnesium supplementation in this population.

26 June 2026 in Medicine
Verified
Journal Article
Open access
TNThanh Luan Nguyen
Thanh Luan Nguyen
TNThi Bao Yen Nguyen
Thi Bao Yen Nguyen
NNNgoc Nhu Y Nguyen
Ngoc Nhu Y Nguyen
PHPhan Ngoc An Huynh
Phan Ngoc An Huynh
TBTuyet Phuong Bui
Tuyet Phuong Bui
TNTrieu Hoang Kim Ngan
Trieu Hoang Kim Ngan
The association between early magnesium sulfate administration and outcomes in sepsis remains incompletely understood, particularly in relation to differences in systemic immune–inflammatory status. In this retrospective cohort study using Medical Information Mart for Intensive Care IV (version 3.1), adult critically ill patients with sepsis were included. Systemic immune–inflammation index (SII) was calculated from platelet, neutrophil, and lymphocyte counts obtained within a peri-intensive care unit window (6 hours before to 24 hours after intensive care unit admission). Early magnesium administration was defined as intravenous magnesium sulfate initiated within the same window. The primary outcome was 30-day all-cause mortality. Propensity score matching was performed to balance baseline characteristics. Associations were examined overall and across SII quartiles using stratified multivariable Cox proportional hazards models, with nonlinear relationships explored using restricted cubic splines. Among 12,087 patients, 6039 received early intravenous magnesium. After propensity score matching, 3396 matched pairs were analyzed. Early magnesium administration was associated with lower 30-day mortality overall (15.8% vs 18.3%, P = .007). In stratified analyses, adjusted hazard ratios were 0.66 (95% confidence interval: 0.51–0.87), 0.65 (0.49–0.85), 0.75 (0.59–0.94), and 0.85 (0.70–1.04) across quartiles 1 to 4. Restricted cubic spline analyses showed descriptive attenuation at higher SII values ( P for interaction = .208), without evidence of a statistically definitive interaction. Early magnesium administration was associated with lower 30-day mortality in critically ill patients with sepsis. Although formal interaction testing did not reach statistical significance, adjusted hazard ratios showed a descriptive gradient of attenuation across increasing SII quartiles, directionally consistent across sensitivity analyses. These findings are hypothesis-generating and require prospective validation.

13 May 2026 in Critical Care
Verified
Journal Article
Open access
TNTu Ngoc Nguyen
Tu Ngoc Nguyen
TNThanh Luan Nguyen
Thanh Luan Nguyen
PHPhan Ngoc An Huynh
Phan Ngoc An Huynh
TNTrieu Hoang Kim Ngan
Trieu Hoang Kim Ngan

12 June 2026 in Medicine
Verified
Journal Article
Open access
NTNhuan Thu To
Nhuan Thu To
TBTuyet Phuong Bui
Tuyet Phuong Bui
VHVan Hoang Nam Ho
Van Hoang Nam Ho
QLQuang Dai Le
Quang Dai Le
TNThi Bao Yen Nguyen
Thi Bao Yen Nguyen
TNThanh Luan Nguyen
Thanh Luan Nguyen
The prognostic value of the modified Nutrition Risk in the Critically Ill (mNUTRIC) score in patients with severe and critical Coronavirus disease 2019 (COVID-19) remains insufficiently defined. This study aimed to assess the predictive performance of the mNUTRIC score for in-hospital mortality in patients with severe and critical COVID-19 admitted to the intensive care unit. We conducted a retrospective cohort study including 355 critically ill patients with severe and critical COVID-19 admitted to a university-affiliated hospital in Vietnam. The mNUTRIC score was calculated using the first available clinical and laboratory values recorded within the first 24 hours of intensive care unit admission. The primary outcome was in-hospital mortality. Associations between the mNUTRIC score and mortality were assessed using multivariable logistic regression. Predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC). Overall in-hospital mortality was 36.1%. High nutritional risk, defined as an mNUTRIC score ≥5, was identified in 29.6% of patients. In multivariable analysis, the mNUTRIC score remained independently associated with in-hospital mortality (adjusted odds ratio 1.58, 95% confidence interval 1.24–2.02; P < .001). The mNUTRIC score demonstrated moderate discriminative performance for predicting in-hospital mortality, with an AUC of 0.750 (95% confidence interval 0.698–0.803; P < .001). At the optimal cutoff value of ≥4.5, the sensitivity and specificity for predicting in-hospital mortality were 54.7% and 84.6%, respectively. In critically ill patients with severe and critical COVID-19, the mNUTRIC score was associated with in-hospital mortality and demonstrated moderate prognostic performance. Given the retrospective design, these findings should be interpreted with caution and warrant further prospective validation.

6 October 2026 in American Heart Journal Plus: Cardiology Research and Practice
Verified
Journal Article
Open access
TNThanh Luan Nguyen
Thanh Luan Nguyen
HDHoang Ngoc Thao Duong
Hoang Ngoc Thao Duong
TNThi Bao Yen Nguyen
Thi Bao Yen Nguyen
THThuy Oanh Hoang
Thuy Oanh Hoang
NNNgoc Nhu Y Nguyen
Ngoc Nhu Y Nguyen
PHPhan Ngoc An Huynh
Phan Ngoc An Huynh

16 October 2026 in Medicine
Verified
Journal Article
Open access
PHPhan Ngoc An Huynh
Phan Ngoc An Huynh
VLVu Thanh Le
Vu Thanh Le
NLNgoc Thu Le
Ngoc Thu Le
NNNgoc Nhu Y Nguyen
Ngoc Nhu Y Nguyen
VHVan Hoang Nam Ho
Van Hoang Nam Ho
TNThanh Luan Nguyen
Thanh Luan Nguyen
The prognostic value of the systemic immune–inflammation index (SII) in critically ill patients with acute asthma exacerbations remains unclear. This study examined the association between SII and in-hospital mortality. We performed a retrospective cohort study using the MIMIC-IV (v3.1) database, including adult critically ill patients with asthma exacerbations. SII was calculated from laboratory values obtained during the peri–intensive care unit admission period. The primary outcome was in-hospital mortality. Associations were assessed using restricted cubic spline and Cox proportional hazards models, adjusted for confounders. A total of 575 patients were included, with an overall in-hospital mortality of 6.6%. Mortality rates differed significantly across SII tertiles and were highest in tertile 3 (11.5%), compared with tertile 2 (3.6%) and tertile 1 (4.7%) ( P = .003). In Cox proportional hazards models, compared with tertile 2, patients in tertile 3 had a significantly increased risk of in-hospital mortality (unadjusted hazard ratio [HR] 2.88, 95% confidence interval [CI] 1.21–6.83, P = .016; adjusted HR 2.82, 95% CI 1.12–7.10, P = .027), whereas no significant difference was observed for tertile 1. Restricted cubic spline analysis based on natural logarithm-transformed (ln-SII) demonstrated a significant nonlinear association with in-hospital mortality ( P for nonlinearity < .001), with risk increasing markedly at higher ln-SII levels. Elevated SII was associated with increased in-hospital mortality and may serve as a simple prognostic marker in critically ill asthma exacerbations.